Author Index
Search or browse for an author across our entire electronic archive
Search results for: O
Results 61 - 70 of 688 shown below
O'Connell, P
S Oesterreich, D C Allredl, S K Mohsin, Q Zhang, H Wong, A V Lee, C K Osborne and P O'Connell
High rates of loss of heterozygosity on chromosome 19p13 in human breast cancer
doi:10.1054/bjoc.2000.1606
O'Connor, A E
A T Byrne, A E O'Connor, M Hall, J Murtagh, K O'Neill, K M Curran, K Mongrain, J A Rousseau, R Lecomte, S McGee, J J Callanan, D F O'Shea and W M Gallagher
Vascular-targeted photodynamic therapy with BF2-chelated Tetraaryl-Azadipyrromethene agents: a multi-modality molecular imaging approach to therapeutic assessment
advance online publication, 2009-10-13 00:00:00.000;
doi:10.1038/sj.bjc.6605247
Abstract | Full article | PDF
O'Connor, D
X-H Wang, D O'Connor, M Brimmell and G Packham
The BAG-1 cochaperone is a negative regulator of p73-dependent transcription
advance online publication, 2009-03-17 00:00:00.000;
doi:10.1038/sj.bjc.6604985
Abstract | Full article | PDF
O'Connor, J P
S B Donaldson, D L Buckley, J P O'Connor, S E Davidson, B M Carrington, A P Jones and C M L West
Enhancing fraction measured using dynamic contrast-enhanced MRI predicts disease-free survival in patients with carcinoma of the cervix
advance online publication, 2009-11-17 00:00:00.000;
doi:10.1038/sj.bjc.6605415
O'Connor, J P B
J P B O'Connor, A Jackson, G J M Parker and G C Jayson
DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents
advance online publication, 2007-01-09 00:00:00.000;
doi:10.1038/sj.bjc.6603515
Abstract | Full article | PDF
O'Connor, O A
O A O'Connor
Clinical experience with the novel histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid) in patients with relapsed lymphoma
doi:10.1038/sj.bjc.6603464
Abstract | Full article | PDF
O'Connor, R
S A Glynn, P Gammell, M Heenan, R O'Connor, Y Liang, J Keenan and M Clynes
A new superinvasive in vitro phenotype induced by selection of human breast carcinoma cells with the chemotherapeutic drugs paclitaxel and doxorubicin
advance online publication, 2004-10-26 00:00:00.000;
doi:10.1038/sj.bjc.6602221
Abstract | Full article | PDF
-
V G Martinez, R O'Connor, Y Liang and M Clynes
CYP1B1 expression is induced by docetaxel: effect on cell viability and drug resistance
advance online publication, 2008-01-22 00:00:00.000;
doi:10.1038/sj.bjc.6604195
Abstract | Full article | PDF
O'Day, S J
K A Jaeckle, S Phuphanich, M J van den Bent, R Aiken, T Batchelor, T Campbell, D Fulton, M Gilbert, D Heros, L Rogers, S J O'Day, W Akerley, J Allen, S Baidas, S Z Gertler, H S Greenberg, S LaFollette, G Lesser, W Mason, L Recht, E Wong, M C Chamberlain, A Cohn, M J Glantz, J C Gutheil, B Maria, P Moots, P New, C Russell, W Shapiro, L Swinnen and S B Howell
Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine
doi:10.1054/bjoc.2000.1574
O'Donnell, A
M Harries, A O'Donnell, M Scurr, S Reade, C Cole, I Judson, A Greystoke, C Twelves and S Kaye
Phase I/II study of DHA–paclitaxel in combination with carboplatin in patients with advanced malignant solid tumours
advance online publication, 2004-10-19 00:00:00.000;
doi:10.1038/sj.bjc.6602196
Abstract | Full article | PDF
-
A O'Donnell, A Padhani, C Hayes, A J Kakkar, M Leach, J M Trigo, M Scurr, F Raynaud, S Phillips, W Aherne, A Hardcastle, P Workman, A Hannah and I Judson
A Phase I study of the angiogenesis inhibitor SU5416 (semaxanib) in solid tumours, incorporating dynamic contrast MR pharmacodynamic end points
doi:10.1038/sj.bjc.6602797
Abstract | Full article | PDF
-
C Benson, J White, J De Bono, A O'Donnell, F Raynaud, C Cruickshank, H McGrath, M Walton, P Workman, S Kaye, J Cassidy, A Gianella-Borradori, I Judson and C Twelves
A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days
advance online publication, 2006-12-19 00:00:00.000;
doi:10.1038/sj.bjc.6603509
Abstract | Full article | PDF
O'Donnell, D
A Merrick, F Errington, K Milward, D O'Donnell, K Harrington, A Bateman, H Pandha, R Vile, E Morrison, P Selby and A Melcher
Immunosuppressive effects of radiation on human dendritic cells: reduced IL-12 production on activation and impairment of naïve T-cell priming
advance online publication, 2005-04-05 00:00:00.000;
doi:10.1038/sj.bjc.6602518
Abstract | Full article | PDF
